Dec. 27 Financial Quick Takes: Cirius, Axsome, Abeona, Monopar, Paige.AI, Freeline

Cirius withdraws IPO
Cirius Therapeutics Inc. withdrew its IPO proposal on Dec. 20. The metabolic and liver disease company had filed in January to raise up to $86.3 million in a NASDAQ offering. In November, Cirius’ lead compound MSDC-0602K missed the primary endpoint in

Read the full 439 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers